Adverse Event Reporting
| VAERS ID | 927703 |
|---|---|
| Gender | Female |
| Age | 37 |
| StateCode | FL |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | EH9899 |
| Number of vaccinations | 1 |
| Vaccinated | 2020-12-18 |
| Onset | 2020-12-18 |
| Condition |
Symptoms
- Exposure during pregnancy
- SARS-CoV-2 test positive
Current Illness
Preexisting Conditions
Other Medications
Previous Vaccinations
Allergies
Laboratory Data
Test Date: 20201228; Test Name: Covid test; Test Result: Positive
Write-up
tested positive for Covid a week after receiving the vaccine; tested positive for Covid a week after receiving the vaccine; patient stated that she was pregnant; patient stated that she was pregnant; patient stated that she was pregnant; This is a spontaneous report from a contactable nurse (patient) from a Pfizer sponsored program.
A 37-year-old female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EH9899), via an unspecified route of administration on 18Dec2020 at left deltoid for Covid-19 immunisation.
The patient medical history was not reported.
There were no concomitant medications.
The patient experienced tested positive for Covid a week after receiving the vaccine on 28Dec2020 (as reported), the patient stated that she was pregnant.
The patient underwent lab tests and procedures which included Covid test: positive on 28Dec2020.
The outcome of events was unknown.
; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded.
Further information like confirmative virus genome /nucleic acid detection is needed for meaningful medical assessment.